Status:
COMPLETED
Aurolab Hydrophobic Foldable Intraocular Lens Study
Lead Sponsor:
Aurolab
Conditions:
Cataract
Eligibility:
All Genders
40-65 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate whether hydrophobic intraocular lenses manufactured by aurolab are safe and effective in the surgical treatment of cataract.
Detailed Description
Hydrophobic as the name suggests is fear for water. Hydrophobic foldable IOLs are made from acrylic material. Aurolab has developed its own hydrophobic acrylic material. This material has been subject...
Eligibility Criteria
Inclusion
- Age 40 to 65 years
- Senile Cataract
- Posterior Subcapsular Cataract (PSCC)
Exclusion
- Obviously debilitated patients
- Cardiac and other serious illness
- Diabetic Patients
- Traumatic cataract
- Complicated cataract
- Congenital cataract
- Drug induced cataract
- Shallow anterior chamber
- Poor mydriasis
- Amblyopia
- Pseudo exfoliation (PXF)
- Dense posterior polar cataract (PPC)
- One eyed patients
- Glaucoma
- Uveitis
- Corneal Pathology
- Retinal Pathology
- Intra operative complications like PC rupture, Zonular dialysis
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00449267
Start Date
March 1 2007
End Date
December 1 2007
Last Update
February 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aravind Eye Hospital
Madurai, Tamil Nadu, India, 625020